✦ LIBER ✦

The results of combination chemotherapy with etoposide, ifosfamide and cisplatin in patients with lung cancer (A preliminary report)

Book ID: 122377563
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 139 KB
Volume: 12
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)96398-F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, ifosfamide and etoposide for small cell lung cancer

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Feasibility of combination chemotherapy

Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer

✍ Watanabe, R; Takiguchi, Y; Moriya, T; Oda, S; Kurosu, K; Tanabe, N; Tatsumi, K; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

A phase II study of ifosfamide, cisplati

A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: A preliminary report

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 169 KB

208 Neoadjuvant chemotherapy ifosfamide

208 Neoadjuvant chemotherapy ifosfamide etoposide and cisplatin (VIP) in 50 patients with non small cell lung cancer (NSCLC)

✍ Roux, D.; Taiar, M.; Bay, J.O.; Kwiatkowski, F.; Escande, G.; Bardet, E.; Verrel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Combination chemotherapy with bleomycin,

Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Combination chemotherapy with cisplatin

Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer

✍ F. Figoli; A. Veronesi; M. G. Trovo; D. Errante; M. Della Valentina; V. Zagonel; 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 447 KB

A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)